Sign up TODAY and try all premium features FREE for a Month!
Sign Up
Home Mf Research Iti Pharma And Healthcare Fund Regular Plan Growth
ITI MUTUAL FUND

ITI Pharma and Healthcare Fund - Regular Plan - Growth

Equity Equity Sectoral Thematic
Fund House : ITI MUTUAL FUND
Overview
Returns
Portfolio
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • SI
NAV (as on 2025-06-20)
15.96 0.71%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
2.34%
Expense Ratio (Direct)
0.43%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-06-13 ₹1,000.00 ₹979.94
-2.01 %
Two Week 2025-06-05 ₹1,000.00 ₹993.04
-0.70 %
One Month 2025-05-21 ₹1,000.00 ₹995.77
-0.42 %
Three Months 2025-03-24 ₹3,000.00 ₹2,991.11
-0.30 %
Six Months 2024-12-23 ₹6,000.00 ₹5,976.38
-0.39 %
One Year 2024-06-20 ₹12,000.00 ₹12,151.31
1.26 %
Three Year 2022-06-21 ₹36,000.00 ₹49,185.39
36.63 %
Since Inception 2021-11-08 ₹45,000.00 ₹63,204.56
40.45 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology Equity 15.18
Divi's Laboratories Limited Pharmaceuticals & Biotechnology Equity 9.12
Max Healthcare Institute Limited Healthcare Services Equity 5.42
Lupin Limited Pharmaceuticals & Biotechnology Equity 5.40
Apollo Hospitals Enterprise Limited Healthcare Services Equity 5.19
Cohance Lifesciences Limited Pharmaceuticals & Biotechnology Equity 4.84
Aurobindo Pharma Limited Pharmaceuticals & Biotechnology Equity 3.93
Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 3.91
Aster DM Healthcare Limited Healthcare Services Equity 3.15
Mankind Pharma Limited Pharmaceuticals & Biotechnology Equity 3.04
Alkem Laboratories Limited Pharmaceuticals & Biotechnology Equity 2.87
Fortis Healthcare Limited Healthcare Services Equity 2.43
Abbott India Limited Pharmaceuticals & Biotechnology Equity 2.33
Wockhardt Limited Pharmaceuticals & Biotechnology Equity 2.28
Granules India Limited Pharmaceuticals & Biotechnology Equity 2.11
Neuland Laboratories Limited Pharmaceuticals & Biotechnology Equity 1.98
FDC Limited Pharmaceuticals & Biotechnology Equity 1.55
Healthcare Global Enterprises Limited Healthcare Services Equity 1.55
Supriya Lifescience Limited Pharmaceuticals & Biotechnology Equity 1.48
Sumitomo Chemical India Limited Fertilizers & Agrochemicals Equity 1.43
Sagility India Limited IT - Services Equity 1.29
Rainbow Childrens Medicare Limited Healthcare Services Equity 1.28
JB Chemicals & Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 1.23
Vijaya Diagnostic Centre Limited Healthcare Services Equity 1.23
Shilpa Medicare Limited Pharmaceuticals & Biotechnology Equity 1.22
Dr. Reddy's Laboratories Limited Pharmaceuticals & Biotechnology Equity 1.22
Gland Pharma Limited Pharmaceuticals & Biotechnology Equity 1.18
GlaxoSmithKline Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 1.18
UPL Limited Fertilizers & Agrochemicals Equity 1.14
Onesource Specialty Pharma Limited Pharmaceuticals & Biotechnology Equity 1.09
Caplin Point Laboratories Limited Pharmaceuticals & Biotechnology Equity 1.08
Linde India Limited Chemicals & Petrochemicals Equity 1.07
Orchid Pharma Limited Pharmaceuticals & Biotechnology Equity 1.03
Cipla Limited Pharmaceuticals & Biotechnology Equity 1.02
Sai Life Sciences Limited Pharmaceuticals & Biotechnology Equity 1.02
Strides Pharma Science Limited Pharmaceuticals & Biotechnology Equity 1.01
Laurus Labs Limited Pharmaceuticals & Biotechnology Equity 0.97
SRF Limited Chemicals & Petrochemicals Equity 0.93
TTK Healthcare Limited Diversified Equity 0.32
Net Receivables / (Payables) - - 0.30
Risk Ratios
Standard Deviation
NA
Beta
NA
Sharpe Ratio
NA
Lock In Period
-
Residual Maturity
NA
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Mr. Rohan Korde (), Mr. Dhimant Shah (), Mr. Rajesh Bhatia (),
  • Expense ration regular : 2.34
  • Expense ration direct : 0.43
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹-
  • Type : equity
Exit load
1% if redeemed or switched out on or before completion of 12 months; Nil thereafter

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?